Skip to main content

Frontiers: University of Kansas Clinical and Translational Science Institute

Frontiers > Funding Opportunities > Pilot Awards > Novel Coronavirus Disease 2019 (COVID-19) Clinical and Translational Research Pilot Study

Novel Coronavirus Disease 2019 (COVID-19) Clinical and Translational Research Pilot Study

The Coronavirus Disease (COVID-19) pandemic is a public health emergency. Successful management, containment and recovery from this virus requires efforts at all levels of society. Frontiers: University of Kansas Clinical and Translational Science Institute invites letters of interest from investigators for funding to develop novel solutions to challenges posed by COVID-19.

Up to two grants of up to $50,000 will be made to support new research initiatives that will make immediate progress towards reducing the harm to individuals, groups, and society from COVID-19. Applicants should describe how these pilot studies will help them to compete successfully for extramural funding.

View the Letter of Interest RFA

All LOIs must be submitted online here by 11:59 PM on Wednesday, April 8, 2020.

Key Dates

  • Letter of Interest Due: April 8, 2020
  • Notifications to Applicants Selected for Full Applications: April 10, 2020
  • Full Proposals and IRB/IACUC Applications Due: April 24, 2020
  • Notification of Award Decision: May 1, 2020
  • Funding Received/Project Start (pending NCATS approval): July 1, 2020

Eligibility

Applicants must have an appointment at a Frontiers institution and be eligible to submit extramural research grant applications. Only one proposal will be accepted per principal investigator. An applicant may be a collaborator on other proposals.

All questions regarding the Frontiers Novel Coronavirus Disease 2019 (COVID-19) Clinical and Translational Research Pilot Study should be directed to frontiers-info@kumc.edu.

Last modified: Apr 01, 2020
ID=x35287